Fig. 10From: Molecular fingerprints of nuclear genome and mitochondrial genome for early diagnosis of lung adenocarcinomaROC analysis of the mutations in LUAD and control plasma cfDNA samples with LASSO. A LASSO model λ value distribution based on nuclear genome mutations in LUAD and control plasma cfDNA samples. B ROC analysis of the mutations of the nuclear genome in LUAD and control plasma cfDNA samples with LASSO. C LASSO model λ value distribution based on the mitochondrial genome mutations in LUAD and control plasma cfDNA samples. D ROC analysis of the mitochondrial genome mutations in LUAD and control plasma cfDNA samples with LASSOBack to article page